Over the past decades, endoscopy, MRI, and serum carcinoembryonic antigen have been the most commonly used prediction models for tumor responses after nCRT.8 These models guide clinicians to select the best treatment for each LARC patient. The gene discussed is CEACAM5; the disease is neoplasm.